Pharmafile Logo
Pharmafocus logo
Advanced Search
Biogen Idec image

Biogen Idec’s MS drug gets European approval

February 4, 2014
Manufacturing and Production, Sales and Marketing Aubagio, Biogen IDEC, EU, MS, gilenya, tecdifera

Biogen Idec’s oral multiple sclerosis drug Tecfidera has won approval in Europe as a first-line treatment for people with relapsing-remitting …

News
Astrazeneca image

AstraZeneca ‘simplifies decision-making’

February 4, 2014
Sales and Marketing AstraZeneca, BMS, Byetta, Forxiga, Onglyza, diabetes

AstraZeneca has completed its $4.3 billion acquisition of Bristol-Myers Squibb’s diabetes business, giving the company control over several big-name brands …

News
sir michael parkinson image

Sir Michael Parkinson criticises NICE

February 4, 2014
Medical Communications, Sales and Marketing Astellas, NHS, NICE, Xtandi, parkinson, prostate

TV host Sir Michael Parkinson has told NICE that it must lift the restrictions imposed on Astellas’ new prostate cancer …

News
screen_shot_2014-02-04_at_08

Sartorius hires laboratory manager

February 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michael Melingo, satorius

Lab and technology firm Sartorius has appointed Michael Melingo to be its laboratory manager. Melingo is to succeed Dominique Baly …

Appointment
Roche image

Roche: NICE guidance ‘perverse’

February 4, 2014
Sales and Marketing NHS, NICE, NSCLC, Roche, Tarceva

Roche has poured scorn on NICE’s ‘perverse’ recommendation that its EGFR-TK inhibitor Tarceva should no longer be given to NHS …

News
J&J image

J&J reveals more on transparency policy

February 3, 2014
Medical Communications, Research and Development, Sales and Marketing Goldacre, J&J, JJ, alltrials, johnson, transparency, yoda

Johnson & Johnson’s pharma subsidiary Janssen has given Pharmafile more details on its new transparency policy, which will see both …

News
Abbvie image

AbbVie ‘pleased’ with first year

February 3, 2014
Sales and Marketing AbbVie, Abbott, CLL, EMA, HIV, Humira

Rheumatoid arthritis treatment Humira – as expected – has driven AbbVie in its first year as a standalone company, accounting …

News

Scotland reforms will see drug access improve

February 3, 2014
Sales and Marketing PACE, SMC, Scotland, drugs, neil

Scotland is set to overhaul its medicines access system after complaints from charities and interest groups that patients have been …

News

Teva/VCCP on top at PM Society ad awards

February 3, 2014
Medical Communications, Sales and Marketing 2014, Teva, ads, advertising, neil smith, pm awards, vccp

Teva and its agency partner VCCP took home the most wins from this year’s PM Society Advertising Awards that featured …

News
CDF image

Cancer Drugs Fund: assessing a difficult legacy

February 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, adams, mccafferty

England’s Cancer Drugs Fund (CDF) is very good at creating division: its lobbyists say that it increases access to new …

Feature
eddie_williams_novo

Novo Nordisk makes Eddie Williams senior VP

February 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, eddie williams

Novo Nordisk has promoted Eddie Williams to the position of senior vice president of its biopharmaceuticals unit. Williams brings three …

Appointment
Lilly image

Sanofi files Lilly lawsuit

February 3, 2014
Sales and Marketing FDA, Lantus, Sanofi, lilly

A row which has been brewing between Sanofi and Eli Lilly & Company has now erupted with the French manufacturer …

News
Aerial view of Milton Park image

UK invests in Oxford bioscience site

January 31, 2014
Research and Development, Sales and Marketing Milton Park, Oxford, UK, bioscience, government

The government is putting £7 million into Milton Park, near Oxford, to boost the building of a new laboratory and …

News
Nintendo chief Satoru Iwata image

Nintendo plans new healthcare venture

January 31, 2014
Medical Communications, Sales and Marketing digital, games, healthcare, nintendo, wii

Console giant Nintendo has confirmed that it is about to set up a new healthcare business separate from its entertainment …

News
cornelius_merlini_metamark

Metamark names new chief commercial officer

January 31, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cornelius, metamark

US Biotech firm Metamark Genetics has named the former general manager of HealthTronics Laboratory Solutions Cornelius Merlini, as its senior …

Appointment
Lilly image

Lilly to go ‘on offense’

January 31, 2014
Sales and Marketing Alimta, Lechleiter, cymbalta, lilly, q4, zyprexa

The loss of patent on antidepressant Cymbalta in the US last December was largely responsible for Eli Lilly & Co’s …

News
Roche image

Oncology drives Roche profits

January 30, 2014
Sales and Marketing Actemra, Perjeta, Roche, Swiss, q4

Sales at Roche’s pharma division rose 7% year-on-year in 2013, driven largely by strong performances from its oncology portfolio. Group …

News

Stem cell breakthrough heralded by scientists

January 30, 2014
Research and Development, Sales and Marketing BBC, regenerative medicine, stap, stem cell

Researchers have discovered a simple method of producing mice stem cells that could mark a new era of regenerative medicine.  …

News
Johnson and Johnson image

UPDATED: J&J in ‘game-changing’ data disclosure plan

January 30, 2014
Medical Communications, Research and Development, Sales and Marketing J&J, JJ, all trials, data, transparency, yoda

News
screen_shot_2014-02-04_at_14

Novo Nordisk appoints chief medical officer

January 30, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, todd hobbs

Dr Todd Hobbs has been appointed chief medical officer (CMO) for Novo Nordisk in North America.   In this role …

Appointment
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026